95943 Roissy CdG
58 articles about Guerbet
BioSpace Movers & Shakers, Dec. 20
12/20/2019Pharma, biotech and life sciences organizations strengthen their leadership teams and boards.
BioSpace Global Roundup, Nov. 21
11/21/2019Companies from across the globe provide updates on their businesses and pipelines.
BioSpace Global Roundup, Oct. 17
10/17/2019Companies from across the globe provide business and pipeline updates.
Guerbet and IBM Watson Health announce a second co-development project as part of their strategic partnership for leveraging artificial intelligence in medical imaging
This second agreement is aimed at developing and marketing a software solution to help radiologists and oncologists diagnose and monitor prostate cancer
Guerbet announces group purchasing agreement with Premier to distribute novel microcatheters
Guerbet LLC USA announced a group purchasing agreement with Premier Inc., a leading healthcare improvement company for Guerbet's SeQure and DraKon, two novel microcatheters intended for the infusion of therapeutic agents, contrast media and embolics into peripheral vessels.
Guerbet Announces Transition from Temporary Importation to Regular Supply for Lipiodol® (ethiodized oil) Injection; also introduces new glass vial container - April 1, 2019
U.S. manufacturing change from ampoules to vials reflect Guerbet's commitment to patient safety and innovation in contrast imaging
Guerbet to present its innovative solutions offering for interventional imaging at CIRSE 2018
Guerbet, the global specialist in contrast media and solutions for diagnostic and interventional medical imaging, has announced its presence at the 2018 annual congress of the CIRSE (Cardiovascular & Interventional Radiological Society of Europe), to be held from September 22 to 25, 2018 in Lisbon (Portugal).
Guerbet Announces Commercial Partnership With Imalogix™ to Deliver Diagnostic and Interventional Imaging Care Optimization
Guerbet LLC USA announced today a commercial partnership with Imalogix™, a leader in artificial intelligence process and workflow solutions.
Guerbet Announces AHRA Charitable Contribution to Support Next Generation Leaders in Medical Imaging
Guerbet LLC USA announced a contribution of $50,000 to the Association for Medical Imaging Management (AHRA) "Defining Our Future" campaign
Guerbet Unveils L-F Hydra Vision™ Digital Urological Imaging System
Guerbet LLC USA announced the launch of the L-F Hydra Vision™ Digital Imaging System.
Accurate has developed a range of microcatheters for embolization procedures of tumors and vascular aneurysms.
GUERBET : Gadolinium-Based Contrast Agents: Update on MHLW Decision in Japan
For all GBCAs, "the necessity of MRI scan using gadolinium-based contrast agents should be determined carefully" as stated in the Japanese new package insert.
Guerbet Reinforces its Expertise With the Launch of Contrast&Care, a Contrast Media Injection Management Solution for Radiology Centers
The launch of the solution is part of the strategy of Guerbet to develop a portfolio of digital solutions to optimize the care and management of patients by healthcare professionals.
Guerbet To Take Part In The 65th Edition Of The Journées Francophones de Radiologie Diagnostique et Interventionnelle (JFR)
Guerbet Announces CE Mark For Vectorio, An Innovative Medical Device For cTACE Procedures
Guerbet Statement Following FDA Medical Imaging Drugs Advisory Committee September 8, 2017
FDA Approves Guerbet's Dotarem (Gadoterate Meglumine) For Pediatric Patients Younger Than Two Years
Guerbet: Revenue At June 30, 2017
Guerbet Invests In The Truffle Capital Fund Dedicated To Medical Devices And Biotechnologies
Guerbet Concurs With The PRAC Recommendations On Gadolinium-Based Contrast Agents And Announces Changes To The US Labeling For Its Linear Agent Optimark (Gadoversetamide Injection)